secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2021-11-18T23:59:59+00:00
Accession:  0001193125-21-333913
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad amends credit agreement to add LIBOR fallback, expand EBITDA definition, increase debt/asset sale baskets
--------------------------------------------------------------------------------

- Adds LIBOR replacement language to credit agreement; updates benchmark provisions.
- Expands EBITDA to include non-recurring cash expenses (transaction costs, milestone payments, restructuring).
- Provides unlimited cash and cash equivalent basket measured against leverage ratio, net of cash up to $200M globally.
- Increases baskets for indebtedness, asset sales, cross-defaults, and judgment liens.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/0001193125-21-333913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/d437115d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-333913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer